Substance use disorder in forensic hospitals: A scoping review of practices and interventions Authors: Dane Mauer-Vakil, Erin Pereira, Christopher Canning, Bernard Le Foll, Geoff Bardwell Published: 2026 ABSTRACT AbstractBackgroundSubstance use disorders (SUDs) are prevalent in individuals with mental illness who interact with criminal justice systems, and inpatient forensic hospital care presents a treatment opportunity. Despite recognition that addressing SUD should be a central feature in forensic hospital care, knowledge is limited regarding existing practices. This scoping review addressed the research question: “What is known about the screening, assessment, treatment, and management of SUD in inpatient forensic hospital settings?”.MethodsWe conducted this review in accordance with the Joanna Briggs Institute Manual for Evidence Synthesis and the PRISMA extension for scoping reviews, searching MEDLINE, PsycINFO, PubMed, and Embase databases. Inclusion criteria comprised original, English language, peer-reviewed studies focusing on inpatient substance use practices and interventions in forensic hospitals internationally, and published from database inception to May 13, 2025.ResultsForty-nine articles were included. Most of this research has been conducted in Europe using observational study designs. SUDburden was high, with prevalence estimates varying depending on detection approach. Treatment evidence came mostly from uncontrolled evaluations with small sample sizes of group-based psychosocial interventions. These data show acceptability and improvements in intermediate outcomes, but mixed results on substance use-specific outcomes. Studies highlighted service fragmentation, workforce training gaps, and security-related issues that strained the therapeutic alliance.ConclusionThis review can inform the development of effective SUD treatment pathways and standardized models of care, improving health outcomes and quality of life, and reducing recidivism in this vulnerable population. This work establishes a foundational knowledge base essential for improving forensic hospital services.Keywords: Substance use, Forensic hospital, Psychiatry, Policy, Scoping review, Clinical practice Introduction Individuals with concurrent mental illness and substance use disorders (SUDs) are disproportionately represented in criminal justice and forensic mental health systems (Moore et al., 2020; Olagunju et al., 2022a; Penney et al., 2019). This overrepresentation reflects a complex interplay of social conditions, clinical vulnerabilities, and system-level features. Factors such as impulsivity, trauma exposure, and antisocial behaviours are associated with an elevated risk of aggressive or violent behaviour in some individuals with concurrent disorders (Lagerberg et al., 2025, Swanson et al., 1990, Zhong et al., 2020). However, substance use typically acts as an exacerbating factor that interacts with psychiatric symptoms, social stressors, and situational risks (Pickard and Fazel, 2013). Concurrent disorders also frequently intersect with social issues, including housing instability and homelessness, which can further complicate access to and continuity of mental health services (Hodgson et al., 2024). Such precarious living conditions reduce engagement with mental health services (Kaplan et al., 2019) and increase the likelihood of contact with police (Kouyoumdjian et al., 2019, Zakrison et al., 2004). Previous meta-analyses have shown that the odds of committing an offense is greater for those who use substances compared to those who do not (Sinha and Easton, 1999, Bennett et al., 2008), but these associations weaken when co-occurring mental illness, prior victimization, and socioeconomic disadvantage are accounted for (Pickard and Fazel, 2013). Notably, while violence risk varies considerably across substances, diagnostic groups, and contexts, most individuals with mental illness and SUDs are not violent (Whiting et al., 2021). Importantly, for a subset of people whose mental illness and SUD directly affect their legal capacity, criminal justice involvement may result in designations of Unfit to Stand Trial (UST) or Not Criminally Responsible on Account of Mental Disorder (NCRMD), leading to diversion into secure forensic mental health hospitals (Chaimowitz et al., 2022, Olagunju et al., 2018). People receiving inpatient forensic mental health care frequently arrive with untreated concurrent disorders and extensive histories of trauma, institutionalization, and social exclusion. SUDs are highly prevalent in this vulnerable population (Kivimies et al., 2012, Kraanen et al., 2012, Ogloff et al., 2004, Penney et al., 2019), oftentimes predating an index offence and continuing through hospitalization (van der Kraan et al., 2014). Forensic mental health systems are comprised of services that assess and treat the mental health and criminogenic needs of individuals who intersect with criminal justice and legal systems (Crocker et al., 2017). It serves individuals whose mental health is pertinent to trial participation and/or criminal responsibility and consists of various services, including psychiatric assessment and evaluation, inpatient psychiatric hospital treatment, and outpatient and community services (e.g., rehabilitation, supportive housing, vocational training). Forensic mental health systems aim to strike a balance between individual treatment and public safety, emphasizing rehabilitation as opposed to punishment. The legal frameworks that guide decisions about mental illness in relation to fitness to stand trial and criminal responsibility vary across jurisdictions and are described elsewhere (Beis et al., 2022, Crocker et al., 2017, Crocker et al., 2022). Forensic mental health systems commonly include independent oversight bodies that review detention, discharge, and community reintegration processes. One critical branch of forensic mental health systems is that of inpatient forensic hospital care. Practitioners that commonly work in this space are medical doctors and nurses who have undergone subspecialty training in forensic psychiatry. A key role of the forensic psychiatrist is to conduct psychiatric assessments, including evaluations of fitness to stand trial and criminal responsibility. Both forensic psychiatrists and nurses provide treatment in secure forensic hospitals, with various other practitioners assisting with frontline care (e.g., forensic/patient care assistants, therapists, counsellors). In the United States, forensic psychiatry is typically practised within state-based mental health systems, with variation in how services are organized across jurisdictions. The core functions typically include competency-to-stand-trial and criminal responsibility evaluations, alongside treatment delivered in specialized forensic units, state hospitals, general psychiatric facilities, and in some cases correctional settings (Crocker et al., 2017; Wik et al., 2020). In Canada, forensic psychiatry is similarly organized at the provincial and territorial level via service provision in secure forensic units within psychiatric hospitals, although models of service delivery vary across the country (Beis et al., 2022, Crocker et al., 2017). In other jurisdictions, forensic psychiatry services are commonly delivered through secure inpatient hospitals or specialist forensic units, sometimes complemented by outpatient and community-based services (Salize et al., 2023, Völlm et al., 2018). Globally, the high prevalence of SUD in forensic psychiatry populations (Kivimies et al., 2012, Kraanen et al., 2012, Ogloff et al., 2004, Penney et al., 2019) significantly influences clinical management and legal outcomes (Simpson et al., 2015). A systematic review, whereby 12 of the 14 included studies were conducted in the United States, documented this high prevalence across several jurisdictions, emphasizing their strong association with negative outcomes, including elevated recidivism risk and poor treatment response (Marquant et al., 2021). Diagnosis, treatment, and rehabilitation are complicated when mental illness is comorbid with SUDs in forensic patients. This is evidenced by the association of SUDs with longer hospitalization, more significant criminal histories, and antisocial behaviour (Hilton et al., 2018, Olagunju et al., 2022a, Olagunju et al., 2022b, Olagunju et al., 2024). In Canada, recent studies have shown elevated rates of SUD among patients under forensic hospital care. For example, an Ontario population-based review of forensic hospital patients reported that 57.2% had a diagnosed SUD, with psychotic spectrum disorders and prior criminal justice involvement commonplace (Chaimowitz et al., 2022). Similarly, Hilton et al. (2018) found that among high-secure forensic inpatients with a major mental illness, 61% met diagnostic criteria for a co-occurring SUD, yet only 19% were diagnosed as such. This underscores a substantial under-recognition, and thus underdiagnosis, of SUD as a concurrent health issue. This may contribute to a lesser likelihood of SUD being considered as a criminogenic need, with care planning implications. Overall, SUDs contribute considerably to the complexity of risk management in forensic psychiatry populations, highlighting the need for integrated treatment approaches. Substance use plays a role in shaping clinical and criminogenic needs within forensic mental health care. For example, alcohol use is strongly associated with violent crime due to its impact on aggression and impulsivity (Fazel et al., 2009). Alcohol-related offenses are common in forensic psychiatry populations, and those with alcohol use issues experience lengthy hospitalizations (Simpson et al., 2015). Notably, alcohol use is more prevalent compared to other substances; hazardous drinking, as defined by World Health Organization (WHO) criteria has a global prevalence of 39.5% (World Health Organization, 2018). Cannabis, the third most used substance globally after alcohol and tobacco (United Nations, 2020), may contribute to psychosis or behavioural disturbances, and is associated with non-violent offenses (Hoch et al., 2015). Importantly, the American legal landscape surrounding cannabis is evolving, with more states permitting use for medical purposes (40 states) and some also recreationally (24 states; National Conference of State Legislatures, 2025). Despite recognition that addressing SUD should be a central feature in forensic hospital care, knowledge is limited regarding existing practices. As a result, it is unclear how SUD is managed in inpatient forensic hospital settings. Two evidence syntheses have examined similar topics, but neither map the broader SUD care literature in forensic hospitals. Eagle et al. (2019) reviewed models of care for concurrent mental illness and substance use across inpatient rehabilitation settings, reporting an absence of studies specific to secure forensic settings, thus requiring reliance on evidence from other contexts (Eagle et al., 2019). In contrast, Krishnan and Ireland (2025) focused solely on structured, group-based, psychosocial substance use interventions for forensic inpatients with dual diagnosis, rather than the full range of SUD hospital care. Thus, a scoping review methodology is warranted to map this broader literature. This study addresses the following research question: “What is known about the screening, assessment, treatment, and management of SUD in inpatient forensic hospital settings?”. Methods This study employed a scoping review of peer-reviewed literature for knowledge synthesis purposes. This approach was appropriate given the need to broadly map the literature (Arksey and O’Malley, 2005). We conducted this review in accordance with the Joanna Briggs Institute (JBI) Manual for Evidence Synthesis (Aromataris et al., 2024), which is a widely recognized scoping review framework. Further, we conducted our reporting according to the Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR); see Appendix A for checklist (Tricco et al., 2018). This scoping review provides an inclusive overview of current practices as evidenced in the peer-reviewed literature. Search strategy and study selection criteria A preliminary search was conducted and no current or underway scoping or systematic reviews on the topic were identified. We developed the search strategies iteratively. The first author identified five articles as benchmark sources to prepare a shortlist of text and index terms. This list was expanded upon and finalized via discussion between the first, second, and last author. The second author conducted the searches in MEDLINE, PsycINFO, PubMed, and Embase databases on May 13, 2025, adapting the search strategy as per database requirements. Please see Appendix B for the search terms and strategy. The inclusion criteria comprised original, English language, peer-reviewed research studies that focused on inpatient substance use practices and interventions in forensic hospitals internationally, and were published up to May 13, 2025. Please see Appendix C for the detailed eligibility criteria. The review was registered with Open Science Framework on May 31, 2025 (https://osf.io/zjdb2/overview). Source of evidence selection After the search was conducted, all identified source citations were uploaded to Zotero and then subsequently to Covidence (a web-based workflow tool for managing evidence syntheses). Duplicates were then removed. The first and second author conducted pilot reviews whereby articles were assessed at the title and abstract stage and discussion ensued with the last author to confirm eligibility- and process-related concerns. Once high agreement (>95%) was attained (two cycles of 10 articles each), the first and second authors independently reviewed all titles and abstracts via application of the eligibility criteria. At the full-text stage, both first and second authors read each article in full to assess compliance with the eligibility criteria. Any disagreements arising at any stage of this review were resolved via consensus discussion with the last author. Reasons for exclusion were selected in Covidence as per standard review methodology protocol (Arksey and O’Malley, 2005, https://jbi-global-wiki.refined.site/space/MANUAL, Tricco et al., 2018). We contacted the authors of papers that could not be retrieved. We also screened the sources in the reference lists of all initially included papers in accordance with JBI requirements (Aromataris et al., 2024). Articles selected for inclusion moved forward to the data extraction phase. Please see the PRISMA Flow Diagram for full search and study inclusion details (Fig. 1). PRISMA Flow Diagram. Data extraction and analysis The first author used Covidence to facilitate data extraction for the papers included in this review (see Appendix D for study details). A broad and all-encompassing definition of ‘substance use’ was employed in this review (i.e., database search, data extraction, data analysis) given the plethora of terminology used in both the academic literature and in public discourse (see Appendix E for a full list of terms). Regarding data analysis, the first author stratified the dataset by the ‘Focus’ data element, which mapped directly onto the research question: screening, assessment, treatment, and management. Subsequent steps ensued where the extracted results were reviewed, cross-referencing various data elements to organize the data in coherent themes. These are presented in the following section. Results Study characteristics Study publication dates ranged from 1995 to 2024; most were published since 2010 (n = 32). Most studies (n = 39) were based in Europe, with the United Kingdom as the location where most of this research occurred (n = 28). The other European study jurisdictions were Germany, Sweden, Ireland, and the Netherlands. Some studies were conducted in North America (Canada – 4; United States – 2) and Australia (n = 4). Most of the studies focused on management (n = 36) and treatment (n = 32). Other foci included: screening and assessment; staff perceptions and attitudes; implementation; and prevalence. Notably, these categories are not mutually exclusive (i.e., many studies spanned multiple focus areas). Almost half of the studies (n = 22) named a specific forensic hospital where the research took place. Regarding general study design, most were quantitative (n = 36). Qualitative (n = 8) and mixed methods (n = 5) studies were also conducted. The most frequently employed specific study design was cross-sectional observational (n = 16). About half of the studies had sample sizes of less than 50 participants (n = 24) and about three quarters had less than 100 (n = 37). Studies with larger sample sizes were less common (n = 4 - ≥200; n = 2 - 150–199). Study population characteristics Most study participants were patients (n = 38), followed by staff (n = 8), and both patients and staff (n = 3). Regarding age, the studies were predominantly adult-focused (n = 35). Age was not reported in 11 studies, and youth-only samples were rare (n = 1). Over half of the studies had mixed sex/gender samples (n = 25), with nearly a third being male-only (n = 15). Female-only samples were rare (n = 1), and several studies did not report sex/gender. Most studies did not report the ethnicity of their sample. When reported, samples were comprised of various ethnicities (n = 10) or majority White/European (n = 8). The studies’ patient diagnoses were mostly categorized as ‘primarily psychotic disorders (± comorbidities)’ (n = 31). The most stated comorbidities were SUDs and personality disorders. In some cases, the diagnoses were not specified (n = 8) or did not apply due to staff-only studies (n = 6). The study institutions’ security-levels were: high (n = 16), medium (n = 15), low (n = 2), combination of low and medium (n = 8), and not specified (n = 8). Thematic overview Prevalence SUD prevalence was estimated in eight observational studies. It was operationalized in three ways: (1) patient-level history and/or diagnosis using standardized assessments and/or medical chart review; (2) period prevalence via urine drug screen testing; and (3) staff perceptions captured via questionnaires/surveys. A high burden of substance use and psychiatric comorbidity was a consistent finding across studies that quantified patient-level SUD prevalence and substance use history (Bloye et al., 2003; Cappai et al., 2017; Nicholls et al., 2011). Notably, these prevalence estimates varied by measurement approach (e.g., structured diagnostic interviews, clinician ratings/standardized scales, self-report screening tools, routine clinical assessments). Findings suggest that most patients report lifetime substance use, with cannabis often the most reported drug (67% in a medium-secure United Kingdom sample), alongside substance use patterns for other drugs exceeding community comparators (Bloye et al., 2003). Another study showed that patients with pre-admission substance dependence exhibited more in-hospital substance use paralleling behaviour and made more pro re nata medication requests compared to those without such a history (Schaefer et al., 2011). Prevalence estimates were high when screening instruments were used. For example, 89% of patients in a United Kingdom sample reported having a substance use history (Cappai et al., 2017), while 67% of men and 62% of women met criteria on a structured risk/treatability measure in a Canadian sample (Nicholls et al., 2011). Across studies using urine drug screen testing to estimate in-hospital substance use, positivity rates were highly contingent on testing practice. For example, factors at play included whether testing was random versus risk-based, the consistency of implementation, and the interpretation of results (Kendrick et al., 2002, MacIntyre et al., 2004, Penney et al., 2021). One study suggested that when testing was inconsistently applied, substantial non-completion rates and irregular testing patterns likely underestimated the true substance use prevalence (Kendrick et al., 2002). In contrast, a study with a systematic testing protocol showed meaningful levels of positive screens (most commonly cannabis and alcohol), but cautioned that there were notable proportions of diluted samples which suggest tampering (Penney et al., 2021). Importantly, positivity rates can also be inflated by prescribed medications. In one study, false positive rates were driven largely by medication, while all true positives were the result of substance use prior to hospital admission (MacIntyre et al., 2004). Staff perceptions of prevalence captured via questionnaires/surveys support substance use as common in secure inpatient forensic settings, even where precise patient-level estimates are not available. Durand et al. (2006) surveyed clinical staff, estimating that a mean of 65% of in-patients had a problem with substance use (range 15–100%), while a questionnaire study described substance use as a “major problem” (Whyte and Harrison, 2004). Staff reported that in-hospital drug use was primarily cannabis-driven, with high estimates of patients using the substance (McKeown and Liebling, 1995). These service-level perspectives indicate less precision regarding SUD prevalence, albeit still pointing toward high burden. Treatment and management Thirty-eight studies examined the treatment and/or management of substance use in inpatient forensic hospital settings, most commonly focusing on program characteristics and/or outcomes. Among program-focused studies (n = 21; Appendix F), structured psychosocial and skills-based approaches were common, usually delivered in group formats, although sometimes alongside individual sessions. Key program elements included cognitive behavioural therapies (CBT), motivational interviewing, cognitive remediation therapy, motivational or stages-of-change approaches, and psychoeducation (Baker et al., 2014, Downsworth and Jones, 2014, Edwards et al., 2011, Glassmire et al., 2007, Long et al., 2010, Marcer et al., 2016, Miles et al., 2007, Miles, 2015, Milosevic et al., 2018, Morris and Moore, 2009, Oddie and Davies, 2009, Parsons et al., 2022, Ritchie et al., 2004, Ritchie et al., 2010, Ritchie et al., 2011, Tibber et al., 2015, Van Der Laan and Janssen, 1996). Programs typically combined multiple modalities and were commonly framed around relapse prevention. Several interventions were explicitly tailored to forensic inpatient contexts by integrating substance use with broader behavioural and risk management practices. These included values-based approaches, skills for managing emotions/urges, and aggression/behavioural regulation techniques (Johnson et al., 2019, Ritchie et al., 2011, Wettermann et al., 2020). Notably, one study employed a dual diagnosis CBT approach that explicitly addressed gender-specific issues related to trauma, mental health, index offence, and lifestyle (Long et al., 2010). Regarding program duration and frequency, the “dose” varied considerably. Some interventions were delivered approximately weekly in groups formats over several months (Miles, 2015, Miles et al., 2007), while others employed higher intensity schedules, for example two sessions per week over several months (Milosevic et al., 2018). Very few studies ran for long periods of time (e.g., 9–14 months). Evidence on effectiveness was mixed and often limited by small samples and predominantly uncontrolled pre–post designs. Outcomes were mostly intermediate, for example readiness to change (Baker et al., 2014, Long et al., 2010), substance-related knowledge and skills acquisition (Milosevic et al., 2018, Ritchie et al., 2010, Tibber et al., 2015), and self-efficacy/confidence to resist substance use in high-risk situations (Long et al., 2010, Ritchie et al., 2004). Program acceptability and satisfaction were generally high (McFadden et al., 2020, Miles, 2015). Patient engagement was a central theme across various studies, often reporting descriptive results via program attendance and retention. Some interventions achieved reasonably strong engagement, as evidenced by high program attendance and satisfaction scores (Baker et al., 2014, McFadden et al., 2020, Miles, 2015). Qualitative studies emphasized peer support and the therapeutic alliance as central to engagement (Ritchie et al., 2011), particularly when treatment explicitly acknowledged the complexity of dual diagnosis in the forensic inpatient context (Krishnan and Ireland, 2025, Svensson et al., 2024). The findings were mixed where objective substance use-specific outcomes were available. Some studies reported abstinence among completers, encouraging healthier long-term substance use patterns (Miles et al., 2007, Miles, 2015, Van Der Laan and Janssen, 1996), whereas others found that gains in knowledge and perceived relapse prevention skills did not translate to reduced substance use (Milosevic et al., 2018). Qualitative studies also reinforced perceived benefits (e.g., increased awareness, social and coping strategies, values-based goal setting, positive impact of group work), while highlighting heterogeneity in patient interpretations and intent to change (Edwards et al., 2011, Johnson et al., 2019, Morris and Moore, 2009, Ritchie et al., 2011). Comparative evidence was rare. One study comparing the Reasoning and Rehabilitation Program to a Dialectical Behavioural Therapy group found similar improvements on cognitive outcomes, with minimal differences between the approaches (Wettermann et al., 2020). Although not quite established programs, two studies explored neurofeedback therapy (Fielenbach et al., 2018, Fielenbach et al., 2019). These studies suggested potential positive measurable effects on targeted neurophysiological markers (e.g., drug craving and motor impulsivity), although the broader clinical implications for substance use management remain underdeveloped (Fielenbach et al., 2018, Fielenbach et al., 2019). Screening and assessment Nineteen studies focused on screening and/or assessment of substance use in inpatient forensic hospital settings, with emphasis on clinical utility, service-level practice, and the psychometric properties of relevant tools. Overall, the literature spans brief screeners and dependency measures (Cappai et al., 2017, Ford, 2003), personality- and trait-based measures (Berlin et al., 2023, Lincourt et al., 2020), and structured instruments for characterizing severity, knowledge, confidence, self-esteem, motivation, and relapse prevention skills (Milosevic et al., 2018, Ritchie et al., 2004, Tibber et al., 2015). In one study drawing on a sample of patients primarily with SUD, assessment scores via the Psychopathy Checklist – Revised did not differentiate between completers and non-completers of substance use treatment (Berger et al., 2012). Substance use detection was also embedded within broader risk assessment tools and service-level practice. For example, the Short-Term Assessment of Risk and Treatability (START) showed strong interrater reliability and, in some studies, predictive validity, but substance use-specific prediction was not consistently supported (Desmarais et al., 2012, Nicholls et al., 2011, O'Shea and Dickens, 2015). At the service level, basic unit surveys show widespread substance use, but variable service provision across settings (Durand et al., 2006, Sandbrook et al., 2015). Furthermore, implementation work emphasized the practical challenges of embedding standardized substance use-specific assessment into routine forensic hospital care (Green et al., 2023). As noted previously, routine urine drug screening was an important clinical practice, although detection and interpretation was impacted by testing coverage, setting, and patient adherence (Kendrick et al., 2002, MacIntyre et al., 2004, Penney et al., 2021, Van Der Laan and Janssen, 1996). Staff perspectives and attitudes Thirteen studies examined staff perspectives and/or attitudes toward substance use, patients, and related service provision in inpatient forensic hospital settings, with workforce capability gaps and therapeutic alliance issues emerging as central themes. Even among qualified staff, substance use training was oftentimes described as inadequate (Barry et al., 2002, Sandbrook et al., 2015), alongside expressed sentiments of uncertainty about “best practice” in day-to-day clinical operations (Dolan and Kirwan, 2001). An earlier staff survey also documented knowledge deficits about substance use, making explicit calls for systematic and coordinated training with clearer guidance (McKeown and Liebling, 1995). Relatedly, a study drawing on a sample of forensic nurses showed their attitudes towards people who use drugs to be suboptimal, reinforcing the need for training that targets substance use knowledge (Foster and Onyeukwu, 2003). At the service level, staff described heavy reliance on written policies and security procedures, but with variability in how substance use was perceived and the orientation of unit policies (i.e., abstinence versus harm minimization) (Durand et al., 2006). Workforce issues also reflected broader system constraints. For example, staff commonly perceived substance use as a “major problem” regarding its impact on patients’ mental disorders and/or response to treatment. Furthermore, they reported limited treatment options and weak linkages to community addictions services, narrowing what hospital clinicians can feasibly deliver (Whyte and Harrison, 2004). Qualitative work further highlights system-level barriers, including the concern that an “artificial abstinence environment” may limit opportunities for frontline staff to observe substance use improvement on the part of their patients (Krishnan and Ireland, 2025). A persistent theme across this subset of studies is that substance use care in these specialized settings creates relational strain between patient and clinician whereby control-oriented practices overlap with therapeutic objectives. Staff described concerns that onsite substance use undermines mental health treatment and service operations, and many worried about negative impacts on the therapeutic alliance (Dolan and Kirwan, 2001, Querengässer et al., 2019). Some staff also viewed inpatient substance use as driven by “personal enjoyment” and perceived such drug use as a “form of antisocial behaviour,” which could complicate constructive clinical engagement (Dolan and Kirwan, 2001). Qualitative evidence suggested that intrusive practices, like strip searches, could further damage the therapeutic relationship (Price, Wibberley, 2012). Further evidence suggested some staff reported challenges reconciling their roles of clinician and “warden” (Green et al., 2023). Notably, stigma may also constitute an issue in this context. In one study, patients with histories of amphetamine or opiate use were more likely to be labelled “drug-seeking” (Kaur et al., 2009). In another study, therapists emphasized insufficient effort or motivation on the part of their patients regarding substance use treatment progression (Querengässer et al., 2019). Discussion This scoping review maps the literature on the screening, assessment, treatment, and management of SUD in inpatient forensic hospital settings. We reviewed 49 articles and summarized the results into the following themes: prevalence; treatment and management; screening and assessment; and staff perspectives and attitudes. Our findings indicate high prevalence alongside detection challenges, mixed evidence on treatment outcomes, and relational strain in the therapeutic alliance. Across the included studies, the estimated prevalence of SUD in forensic hospitals varied depending on how it was defined (see Appendix E for the diverse substance use terminology in the included papers) and assessed (e.g., chart diagnosis, structured tools, urine drug screening, staff estimates). This heterogeneity complicates our understanding of the magnitude of the issue. This contributes to under-detection in these clinically complex settings where response bias, obscure symptomatology, and psychometric limitations simultaneously complicate identification. This underdiagnosis presents a serious concern in forensic mental health. If SUD is not accurately detected, it is less likely to be considered a criminogenic need, and integrated into risk assessment and treatment planning. Such underdiagnosis has been clearly shown in a Canadian sample: of 491 forensic inpatients with a major mental illness, 61% met diagnostic criteria for a co-occurring SUD, yet only 19% were formally diagnosed with both conditions (Hilton et al., 2018). Of particular concern in the forensic context is that of cannabis, which has been shown to exacerbate symptoms among individuals with or at high risk of psychotic disorders (Foti et al., 2010, Grech et al., 2005). While most inpatient forensic hospital settings require complete abstinence from substances, select anecdotes in the North American context suggest substance use is common in lower-security settings, especially those where patients have temporary community release privileges. Notably, substance use among forensic patients is also associated with worse illness trajectories and challenges with community reintegration because of poor medication adherence and high rates of hospital readmissions (Penney, Marshall, and Simpson, 2018), which are compounded by a lack of access to social supports. In addition to current substance use, histories of use appear to be associated with patient profiles and illness trajectories relevant for clinical management in forensic mental health, supporting detection as essential (Schaefer et al., 2011). A considerable gap in this literature is a lack of substance-specific data reporting. For example, population-level research in Ontario, Canada (Chaimowitz et al., 2022) and among Missouri insanity acquittees in the United States (Linhorst, 1997) shows a high burden of SUD, but does not disaggregate by substance type, such as alcohol, cannabis, stimulants, or opioids, each of which carries certain potential clinical and criminogenic implications. This limitation hinders efforts to tailor interventions, train clinical staff, and allocate resources effectively. We recommend future research employ standardized SUD categories aligned with DSM−5 and/or ICD−11 classifications and routinely report substance-specific patterns. Our research group is conducting such research at the institutional level in Ontario, Canada. The treatment literature we reviewed was dominated by studies evaluating structured, group-based psychosocial programs, which were sometimes paired with individual sessions. These interventions were generally acceptable and often improved intermediary outcomes such as readiness to change, knowledge/skill acquisition, and self-efficacy, although effects on substance use-specific outcomes were mixed. Where such indicators were reported, the overall evidence base was constrained by small samples and mostly uncontrolled pre–post study designs. This evidence mirrors a recent review focused specifically on structured group psychosocial SUD interventions for forensic inpatients with dual diagnosis, highlighting limited effectiveness (Krishnan and Ireland, 2025). Importantly, since our review was much broader in scope, we suggest that intervention studies represent just one aspect of a much larger, fragmented forensic mental health landscape. Our findings also extend those of Marquant et al. (2021), who conducted a systematic review exploring how SUD is treated in Forensic Assertive Community Treatment (FACT) and how it relates to key outcome measures. Their work found that SUD was highly prevalent among patients receiving FACT, that SUD severity at intake was key in determining whether patients entered FACT directly from prison or via a care continuum, and that SUD was associated with outcomes such as recidivism and hospitalization. While Marquant et al. (2021) focused solely on community-based forensic treatment and the role of SUD in FACT pathway decision-making, our review builds upon this work by mapping how SUD is identified, treated, and managed within inpatient forensic hospital settings. Taken together, these reviews suggest that SUD is not only a post-discharge or community reintegration consideration, but a clinical, criminogenic, and system-level issue requiring standardized detection, integrated treatment, and coordinated transitions between hospital and community services. An important implication of our findings is the urgency to move beyond a “one-size-fits-all” programming approach toward a more individualized patient-centered model. Theoretically, such an approach would match program content and intensity (i.e., stepped care) to patient readiness, cognitive capacity, and unique substance use symptomatology. The dominance of group-based psychosocial models in the forensic literature stands in contrast with the wider dual diagnosis literature. This evidence base supports the use of various approaches, including group counseling, contingency management, and residential dual diagnosis treatment, showing positive effects on substance use outcomes (Drake et al., 2008). Taken together, the available evidence suggests that forensic hospitals may be drawing, if at all, on a fairly narrow subset of interventions with demonstrated utility in other settings. In the absence of forensic-specific trials with reasonably long-term follow-ups, it will remain unclear which psychosocial approaches are most effective in these highly complex clinical settings. Furthermore, given the lack of longitudinal studies in this literature, it is unclear the proportion of forensic inpatients who return to problematic substance use post-discharge. Future research using large-scale administrative datasets should be conducted to study this phenomenon. A fruitful avenue for future research centres upon mixed methods evaluations, linking health outcomes to program features and hospital contexts. Regarding the latter, our findings on the therapeutic alliance indicate strained relationships and potentially stigmatizing attitudes on the part of clinicians (Dolan and Kirwan, 2001, Green et al., 2023, Kaur et al., 2009, Price and Wibberley, 2012, Querengässer et al., 2019). This begs the critical question as to whether such perspectives have a deleterious impact of the quality of services provided. Qualitative research on the patient-provider relationship would begin answering some of these questions. Additionally, research employing patient-oriented designs, whereby patients are meaningfully involved in the research process, could yield critical information relevant for improving forensic hospital services (Canning et al., 2025). There are limitations to our study. Firstly, we excluded studies published in languages other than English given the linguistic limitations of our research team and a lack of resources for hiring translators. This limitation may help explain the narrow geographical coverage of the included studies (i.e., the European over-representation); it is possible that relevant, non-English studies were excluded. For example, there likely exists a robust literature on our topic in Germany, whereby offenders with SUDs related to their index offenses can be involuntarily admitted to forensic hospitals under Section 64 of the German Penal Code (Schalast et al., 2011). Secondly, our eligibility criteria may have excluded important insights from the grey literature (e.g., clinical guidelines). We recognize that such excluded literature could have added value to our findings. Thirdly, while we employed a broad definition of ‘substance use,’ it is possible that some terms across the literature were omitted that may have been relevant. Fourthly, although scoping reviews are suitable for providing a broad overview of literature and are useful for identifying research gaps, they do not provide a depth of information on a given topic. Finally, we did not conduct a quality assessment of the included studies, in alignment with scoping review guidelines (Arksey and O’Malley, 2005; Tricco et al., 2018). Conclusion This scoping review mapped what is known about the screening, assessment, treatment, and management of SUDs in inpatient forensic hospital settings. Across 49 included studies, SUD burden was high, but the field lacks a consistent measurement and care framework. Prevalence estimates, and by extension the perceived magnitude of the issue, varied substantially depending on how substance use was defined and assessed. This emphasizes that under-detection is a concern in hospital-based forensic care. The evidence base on treatment and management demonstrate that interventions were generally acceptable and frequently improved intermediary outcomes; however, the effects on substance use-specific outcomes were mixed. Concurrently, studies described service fragmentation, workforce training gaps, and security-related issues, limiting implementation and placing strain on the therapeutic alliance. Negative impacts on the patient-provider relationship is an issue with serious consequences in these complex settings where engagement, trust, and safety must be balanced. Altogether, this literature indicates that forensic hospitals are operating within a complex, high-needs environment that employs a narrow and inconsistently evaluated set of approaches. Future research must prioritize: (1) standardized SUD identification aligned with DSM−5 and/or ICD−11 classifications; (2) mixed methods evaluations of inpatient services; and (3) implementation strategies that could improve workforce training and lessen relational strain in the therapeutic alliance. Undertaking this work could support more robust SUD detection processes, higher-quality treatment, improved health and quality-of-life outcomes, and reduced recidivism among forensic psychiatric populations. Our work establishes a foundational knowledge base essential for improving SUD forensic hospital services internationally. This scoping review serves as a resource to build upon for future scholarly work, for health system champions interested in improving forensic services at their organizations, and for policymakers inspired to contribute to forensic mental health system reform. Ethical approvals None. Role of the funding source Dane Mauer-Vakil reports doctoral scholarship support from the University of Waterloo, Canadian Institutes of Health Research, Social Sciences and Humanities Research Council, and Mitacs. Geoff Bardwell reports funding support from Mitacs. These funders were not involved in the study design, collection, analysis, and interpretation of data, nor in the writing of the manuscript and decision to submit the article for publication. CRediT authorship contribution statement Geoff Bardwell: Writing – review & editing, Writing – original draft, Supervision, Funding acquisition, Conceptualization. Bernard Le Foll: Writing – review & editing, Conceptualization. Christopher Canning: Writing – review & editing, Conceptualization. Erin Pereira: Writing – review & editing, Project administration, Investigation, Data curation. Dane Mauer-Vakil: Writing – review & editing, Writing – original draft, Project administration, Investigation, Funding acquisition, Formal analysis, Data curation, Conceptualization. Declaration of Generative AI and AI-assisted technologies in the writing process During the first draft of this paper, the first author used OpenAI ChatGPT 5.2 to assist in editing and condensing text (i.e., improving language and readability). After using this tool, the author reviewed and edited the content as needed and takes full responsibility for the content of the published article. Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests. Geoff Bardwell reports financial support from the University of Waterloo, Canadian Institutes of Health Research, and Vancouver Foundation. Bernard Le Foll has obtained funding from Indivior for a clinical trial. He was part of a Steering Board for an Indivior clinical trial. He will be receiving funding for a clinical trial sponsored by Lilly. Le Foll has received in-kind donations of placebo edibles from Indiva. He is consultant for Shinogi, ThirdBridge, Guidepoint and Changemark. He is part of a scientific advisory board for NFL Biosciences. He is supported by the Centre for Addiction and Mental Health, Waypoint Centre for Mental Health Care, a clinician-scientist award from the Department of Family and Community Medicine at the University of Toronto, and a Chair in Addiction Psychiatry from the Department of Psychiatry at the University of Toronto. Appendix A Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) ChecklistSECTIONITEMPRISMA-ScR CHECKLIST ITEMREPORTED ON PAGE #TITLETitle1Identify the report as a scoping review.1ABSTRACTStructured summary2Provide a structured summary that includes (as applicable): background, objectives, eligibility criteria, sources of evidence, charting methods, results, and conclusions that relate to the review questions and objectives.1INTRODUCTIONRationale3Describe the rationale for the review in the context of what is already known. Explain why the review questions/objectives lend themselves to a scoping review approach.2Objectives4Provide an explicit statement of the questions and objectives being addressed with reference to their key elements (e.g., population or participants, concepts, and context) or other relevant key elements used to conceptualize the review questions and/or objectives.3METHODSProtocol and registration5Indicate whether a review protocol exists; state if and where it can be accessed (e.g., a Web address); and if available, provide registration information, including the registration number.3Eligibility criteria6Specify characteristics of the sources of evidence used as eligibility criteria (e.g., years considered, language, and publication status), and provide a rationale.3, 9Information sources*7Describe all information sources in the search (e.g., databases with dates of coverage and contact with authors to identify additional sources), as well as the date the most recent search was executed.3Search8Present the full electronic search strategy for at least 1 database, including any limits used, such that it could be repeated.9Selection of sources of evidence†9State the process for selecting sources of evidence (i.e., screening and eligibility) included in the scoping review.3Data charting process‡10Describe the methods of charting data from the included sources of evidence (e.g., calibrated forms or forms that have been tested by the team before their use, and whether data charting was done independently or in duplicate) and any processes for obtaining and confirming data from investigators.3Data items11List and define all variables for which data were sought and any assumptions and simplifications made.3, 9-19Critical appraisal of individual sources of evidence§12If done, provide a rationale for conducting a critical appraisal of included sources of evidence; describe the methods used and how this information was used in any data synthesis (if appropriate).N/ASynthesis of results13Describe the methods of handling and summarizing the data that were charted.3RESULTSSelection of sources of evidence14Give numbers of sources of evidence screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally using a flow diagram.Fig. 1Characteristics of sources of evidence15For each source of evidence, present characteristics for which data were charted and provide the citations.3-6Critical appraisal within sources of evidence16If done, present data on critical appraisal of included sources of evidence (see item 12).N/AResults of individual sources of evidence17For each included source of evidence, present the relevant data that were charted that relate to the review questions and objectives.3-6Synthesis of results18Summarize and/or present the charting results as they relate to the review questions and objectives.3-6DISCUSSIONSummary of evidence19Summarize the main results (including an overview of concepts, themes, and types of evidence available), link to the review questions and objectives, and consider the relevance to key groups.6, 7Limitations20Discuss the limitations of the scoping review process.7Conclusions21Provide a general interpretation of the results with respect to the review questions and objectives, as well as potential implications and/or next steps.7FUNDINGFunding22Describe sources of funding for the included sources of evidence, as well as sources of funding for the scoping review. Describe the role of the funders of the scoping review.7JBI = Joanna Briggs Institute; PRISMA-ScR = Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews.* Where sources of evidence (see second footnote) are compiled from, such as bibliographic databases, social media platforms, and Web sites.† A more inclusive/heterogeneous term used to account for the different types of evidence or data sources (e.g., quantitative and/or qualitative research, expert opinion, and policy documents) that may be eligible in a scoping review as opposed to only studies. This is not to be confused with information sources (see first footnote).‡ The frameworks by Arksey and O’Malley (6) and Levac and colleagues (7) and the JBI guidance (4, 5) refer to the process of data extraction in a scoping review as data charting.§ The process of systematically examining research evidence to assess its validity, results, and relevance before using it to inform a decision. This term is used for items 12 and 19 instead of "risk of bias" (which is more applicable to systematic reviews of interventions) to include and acknowledge the various sources of evidence that may be used in a scoping review (e.g., quantitative and/or qualitative research, expert opinion, and policy document).From: Tricco AC, Lillie E, Zarin W, O′Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMAScR): Checklist and Explanation. Ann Intern Med. 2018;169:467–473. doi: 10.7326/M18–0850. Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist JBI = Joanna Briggs Institute; PRISMA-ScR = Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews. * Where sources of evidence (see second footnote) are compiled from, such as bibliographic databases, social media platforms, and Web sites. † A more inclusive/heterogeneous term used to account for the different types of evidence or data sources (e.g., quantitative and/or qualitative research, expert opinion, and policy documents) that may be eligible in a scoping review as opposed to only studies. This is not to be confused with information sources (see first footnote). ‡ The frameworks by Arksey and O’Malley (6) and Levac and colleagues (7) and the JBI guidance (4, 5) refer to the process of data extraction in a scoping review as data charting. § The process of systematically examining research evidence to assess its validity, results, and relevance before using it to inform a decision. This term is used for items 12 and 19 instead of "risk of bias" (which is more applicable to systematic reviews of interventions) to include and acknowledge the various sources of evidence that may be used in a scoping review (e.g., quantitative and/or qualitative research, expert opinion, and policy document). From: Tricco AC, Lillie E, Zarin W, O′Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMAScR): Checklist and Explanation. Ann Intern Med. 2018;169:467–473. doi: 10.7326/M18–0850. Appendix B Search Terms and StrategySetting / PopulationCondition / SubstanceSearch Strategyforensic hospitalforensic inpatientForensic inpatient*Forensic institutionForensic mental health inpatientForensic mental health hospitalForensic psychiatr*AsylumSanitariumsecure psychiatric hospitalHigh-secur* pysch* unitMedium-secur* pysch* unitLow-secur*pysch* unitpsychiatric wardsubstance use* disorderSubstance *useSubstance use disorder*Drug useDrug abusesubstance abusesubstance misusedrug dependenc*Substance dependenc*alcoholpolysubstancePoly-substanceaddictionCannabismarijuanatobaccoStimulantCocainemethamphetamineOpioid*Opiate*sedativeHallucinogenUse disorder(“forensic hospital” OR “forensic inpatient” OR “forensic institution” OR “Forensic mental health inpatient” OR “Forensic mental health hospital” OR “Forensic psychiatr*” OR asylum OR sanitarium OR “secure psychiatric hospital” OR “High-secur* pysch* unit” OR “Medium-secur* pysch* unit” OR “Low-secur*pysch* unit” OR “psychiatric ward”) AND (“substance use* disorder” OR “Substance *use” OR “Substance use disorder*” OR “Drug use” OR “Drug abuse”OR “substance abuse” OR “substance misuse” OR “drug dependenc*” OR “Substance dependenc*” OR alcohol OR polysubstance OR Poly-substance OR addiction OR cannabis OR marijuana OR tobacco OR stimulant OR cocaine OR methamphetamine OR Opioid* OR Opiate* OR sedative OR hallucinogen OR “use disorder”) Search Terms and Strategy . Appendix C Detailed Eligibility CriteriaConceptInclusionExclusion1] PopulationForensicNon-forensic2] InterventionSubstance useNon-substance use3] Setting/ContextInpatient hospitalOutpatient / community-based4] Study Characteristics [Database inception up until May 13, 2025]Original, English language, peer-reviewed research-Not original research: Review, commentary, editorial, erratum, reply/comment, study protocol-Not peer-reviewed: Book, book review, workbook, textbook, chapter, conference proceedings, theses Detailed Eligibility Criteria . Appendix D Extracted Data from Included StudiesAuthor(Year)RegionFocus & Objectives / Research QuestionsStudy DesignData Source / MeasuresSettingParticipantProgramKey FindingsBaker et al., (2014)United KingdomFocus: Treatment; ManagementTo examine the acceptability and possible effectiveness of a manualized cognitive behavioural substance misuse intervention for men in a low secure psychiatric setting.Quantitative-Uncontrolled pre-post(one-group)Pre-measure: Severity of Dependence ScalePre-Post measure: Stages of Change Readiness and Treatment Eagerness (SOCRATES)Post-Group Programme Evaluation QuestionnaireSubstance use at 12-month follow-upInstitution: St Andrew’s HealthcareSecurity Level: LowType: PatientAge Group: AdultsSex/Gender: MaleEthnicity: Not reportedDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: 25–49Format: Group and IndividualDuration: Not specifiedComponents:- Cognitive behavioural therapy- Practising substance refusal skills via psychoeducation, group discussion, group exercises, and role play- Weekly individual homework exercisesThe intervention was well received, with most participants attending a substantial proportion of sessions. Post-treatment findings suggested improved motivation and readiness to change, and most treatment completers remained abstinent at 12-month follow-up.Barry et al., (2002)United KingdomFocus: Management; Staff Perceptions/AttitudesTo assess staff knowledge regarding substance use, attitudes toward substance use and mental illness, and the extent of relevant training among qualified and unqualified nurses, and non-clinical staff.Quantitative-Cross-sectional observationalDrug Knowledge QuestionnaireLikert scales: 1] Agreement with various reasons for substance use in people with mental illness; 2] Agreement with various statements regarding their attitudes towards an in-patient in a medium secure hospital who produced a positive drug testDemographic information (staff type, age, gender)Institution: Not specifiedSecurity Level:MediumType: StaffAge Group: AdultsSex/Gender: MixedEthnicity: Not specifiedDiagnosis: Mixed psychiatric diagnoses Sample Size: 75–99Format: N/ADuration: N/AComponents: N/ASubstance use training was inadequate across staff groups, including qualified staff. Qualified nurses demonstrated greater knowledge of alcohol and illicit drug use than unqualified and non-clinical staff, and differed in their views on why people with severe mental conditions use substances; punitive attitudes did not significantly differ across staff groups.Berger et al., (2012)GermanyFocus: Screening; AssessmentTo examine the total score of the Psychopathy Checklist – Revised (PCL-R) and the score of the affective and interpersonal psychological traits (factor 1) and socially deviant conduct (factor 2) pertaining to the end of treatment by court order.Quantitative-Cross-sectional observationalPsychopathy Checklist-Revised (PCL-R)Institution:The Hospital for Psychiatry and Neurology Hildburg-hausenSecurity Level:MultipleType: PatientAge Group: AdultsSex/Gender: MaleEthnicity: Majority White/EuropeanDiagnosis: Primarily substance use disorderSample Size: 100–149Format: N/ADuration: N/AComponents: N/APatients who dropped out of treatment had higher PCL-R scores than those who completed treatment. Higher PCL-R scores were associated with increased likelihood of dropout, but the results did not identify a clear score threshold that could reliably distinguish completers from non-completers.Berlin et al., (2023)SwedenFocus: Screening; AssessmentTo examine the validity of the Swedish version of the Externalizing Spectrum Inventory-Brief Form (ESI-BF) – Overview, reliability, structural fit, how subscale scores relate to externalizing behaviours, lifetime externalizing disorders, as well as aggressive and antisocial behaviour.Quantitative-Cross-sectional observationalThe Swedish (official and back-translated) version of the Externalizing Spectrum Inventory-Brief Form (ESI-BF) [The Substance Abuse subfactor (ESI-BF SUB) contains 18 items related to recreational and problematic use of alcohol, marijuana, and other substances]The Life History of Aggression AssessmentClinical and criminological measures: File data on lifetime history of psychiatric disorders and criminological variables were collected using a structured data collection form, extracting information from the patients’ medical recordsInstitution: Not specifiedSecurity Level:HighType: PatientAge Group: AdultsSex/Gender: MixedEthnicity: Majority White/EuropeanDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: 75–99Format: N/ADuration: N/AComponents: N/AThe ESI-BF showed adequate to good reliability and internal consistency, but the tested structural models demonstrated poor to moderate fit. Its subscales were associated with aggression, antisocial behaviour, substance-related problems, and some criminal history indicators, alongside possible item redundancy in several facet scales.Bloye et al., (2003)United KingdomFocus: Screening; Assessment; PrevalenceTo compare assessment approaches for identifying substance use disorders, alongside associated clinical and management implications, among patients admitted to a medium secure unit.Quantitative-Cross-sectional observationalSeverity of Dependence Scale (SDS)Clinician rating scales (CRS)Case-note questionnaire (CQ)Participant questionnaire (PQ)Institution: Not specifiedSecurity Level:MediumType: PatientAge Group: Not specifiedSex/Gender: MixedEthnicity: Majority White/EuropeanDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: 50–74Format: N/ADuration: N/AComponents: N/AThe study found a high burden of co-occurring substance use disorders using the three assessment methods. The case-note questionnaire prevalence rates correlated with both other tools. The findings support using a multi-method assessment approach to more accurately detect substance use issues in forensic inpatients.Cappai et al., (2017)United KingdomFocus: Screening; Treatment; Management; PrevalenceTo examine the extent and severity of substance misuse and related treatment needs among patients in a high secure hospital by comparing those with a primary diagnosis of personality disorder to other mental illness (predominantly psychotic disorders).Quantitative-Cross-sectional observationalSubstance misuse (SMU) screening questionnaireInstitution: Broadmoor HospitalSecurity Level: HighType: PatientAge Group: Not specifiedSex/Gender: MaleEthnicity: Not specifiedDiagnosis: Primarily personality disorders (± comorbidities)Sample Size: ≥ 200Format: N/ADuration: N/AComponents: N/ASubstance misuse histories and related treatment needs were common. Patients with other mental illness (predominantly psychotic disorders) generally showed greater substance-related complexity and need than those with personality disorders, underscoring the importance of targeted psychological service provision for substance misuse in high secure settings.Desmarais et al., (2012)CanadaFocus: Assessment; ManagementTo evaluate the reliability and validity of the Short-Term Assessment of Risk and Treatability (START) assessment for predicting inpatient aggression.Quantitative-Cohort observationalThe Short-Term Assessment of Risk and Treatability (START)Historical-Clinical-Risk Management – 20 (HCR−20)Hare Psychopathy Checklist: Screening Version (PCL:SV)Overt Aggression Scale (OAS)Institution: Not specifiedSecurity Level: Not specifiedType: PatientAge Group: AdultsSex/Gender: MaleEthnicity: VariousDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: 100–149Format: N/ADuration: N/AComponents: N/ASTART assessments showed excellent interrater reliability and provided both predictive and incremental validity for inpatient aggression over the HCR−20 subscale scores and the Psychopathy Checklist Short Version total scoresDolan and Kirwan, (2001)United KingdomFocus: Management; Staff Perceptions/AttitudesTo examine staff perceptions of the extent and effects of illicit drug use among patients in a medium secure unit.Quantitative-Cross-sectional observationalQuestionnaire survey: Based on a similar survey conducted in a special hospital setting (McKeown and Liebling, 1995)Institution: Edenfield CentreSecurity Level: MediumType: StaffAge Group: Not specifiedSex/Gender: Not specifiedEthnicity: Not specifiedDiagnosis: N/ASample Size: 50–74Format: N/ADuration: N/AComponents: N/AMost staff reported awareness of illicit drug use on the unit and viewed it as harmful to both patient psychopathology and staff-patient relationships. Staff commonly attributed drug use to “personal enjoyment” and a “form of antisocial behaviour,” alongside reporting limited clarity regarding unit policy and insufficient training in managing dual diagnosis.Downsworth and Jones, 2014United KingdomFocus: Treatment; ManagementTo assess the effectiveness of the Addressing Substance Related Offending-Secure (ASRO-S) program in a secure forensic hospital.Mixed methodsPre–post (quant + qual)The Stages of Change Questionnaire (SOC) - Measuring readiness to changeBarratts Impulsivity Scale – 11th Edition (BIS−11) - Measuring motor, cognitive and non-planning impulsivityLocus of Control of Behaviour - Measuring self-efficacySocial Problem Solving Inventory (SPSI-R:S) - Measuring constructive and effective or defective and dysfunctional problem solving abilityQualitative data was also collected through a feedback activity - All participants were asked their experience of the ASRO-S treatment programInstitution:Roseberry Park HospitalSecurity Level:MultipleType: PatientAge Group: AdultsSex/Gender: MaleEthnicity: Not specifiedDiagnosis: Not specifiedSample Size:< 25Format: GroupDuration:20 sessionsComponents:- Cognitive behavioural group treatment- Target areas: motivation to change; personal awareness and responsibility raising; relapse prevention; lifestyle changeResults indicated little evidence of change across outcome measures, with the only significant difference demonstrating increased non-planning impulsivity (lack of concern for the future) after the program. Qualitative feedback centred upon three themes: enjoyment of the program; support from peers; and relevance of the content.Durand et al., (2006)United KingdomFocus: Assessment; Treatment; Management; Staff Perceptions/Attitudes; PrevalenceTo describe the perceived impact of inpatient substance misuse in medium secure units, including policies, assessment and treatment practices, service capacity, staff expertise and training, links with specialist substance misuse services, and models of care.Quantitative-Cross-sectional observationalSurveys: Unit managers; Forensic psychiatristsInstitution: Not specifiedSecurity Level:MediumType: StaffAge Group: AdultsSex/Gender: MixedEthnicity: Majority White/EuropeanDiagnosis: N/ASample Size: 100–149Format: N/ADuration: N/AComponents: N/ASubstance misuse was reported across all surveyed units and was estimated by consultants to affect a large proportion of inpatients. Most units had written substance use and security policies and some in-house expertise in substance misuse management. Consultants reported that they spent a mean of 4.4 h per month addressing substance misuse issues.Edwards et al., (2011)United KingdomFocus: Treatment; Management; ImplementationTo describe the planning, development, implementation, and evaluation of a structured alcohol and drug group, including attendees’ views of the program, lessons learned, and recommendations for future practice.Qualitative-Case studyInterviewsInstitution: Not specifiedSecurity Level: MediumType: PatientAge Group: Not specifiedSex/Gender: MaleEthnicity: Not specifiedDiagnosis: Not specifiedSample Size: < 25Format:Not specifiedDuration:Not specifiedComponents:- Motivational approach- Contingency management component (for negative drug screens)- Structured goal setting- Drug refusal skills training- Psychoeducation- Relapse prevention trainingThe group was viewed as helpful for increasing awareness of co-occurring substance misuse and for establishing a structured treatment framework. Participants responded most positively to the educational and skills-based components, group composition, and facilitators, while suggesting that sessions were too long, goal-setting was overly repetitive, and more discussion of the implications of substance use was needed.Fielenbach et al., (2018)NetherlandsFocus: Treatment; ManagementTo examine whether theta/sensorimotor rhythm neurofeedback training reduces impulsivity, drug craving, and substance use among forensic psychiatric patients with substance use disorders.Quantitative-Randomized controlled trialElectroencephalographyBarratt Impulsivity Scale−11 (BIS−11)Cued Go/No-Go Task (measure of impulse control)Modified Desire for Alcohol Questionnaire-Short Form (DAQ-SF)Drug use via urine or breathalyzer testingInstitution: Not specifiedSecurity Level: HighType: PatientAge Group: Not specifiedSex/Gender: MaleEthnicity: Not reportedDiagnosis: Mixed psychiatric diagnosesSample Size: 25–49Format: N/ADuration: N/AComponents: N/ANeurofeedback training increased sensorimotor rhythm magnitude, but did not produce improved clinical outcomes versus treatment as usual alone. Drug craving and motor impulsivity decreased in both groups (neurofeedback training group and the treatment-as-usual only group, while other impulsivity measures and substance use showed little change over time.Fielenbach et al., (2019)NetherlandsFocus: Treatment; ManagementTo examine the extent to which forensic psychiatric patients with substance use disorder can learn to regulate neurophysiological activity through theta/sensorimotor rhythm neurofeedback training, and to assess whether changes in frequency bands are associated with changes in impulsivity and substance-related behaviour.Quantitative-Uncontrolled pre–post (one-group)ElectroencephalogramBarratt Impulsiveness Scale−11 (BIS−11)Modified Desire for Alcohol Questionnaire-Short Form (DAQ-SF)Substance abuse: To score substance abuse, the item “substance abuse” on the risk assessment scale Historische, Klinische, Toekomst-Revised (HKT-R) [Historical, Clinical, Future-Revised] was usedCued Go/No-Go Task (measure of impulse control)Institution: Not specifiedSecurity Level: HighType: PatientAge Group: AdultsSex/Gender: Not specifiedEthnicity: Not reportedDiagnosis: Mixed psychiatric diagnosesSample Size: < 25Format: N/ADuration: N/AComponents: N/ALess than a quarter of patients were able to consistently regulate brain activity in the intended direction during neurofeedback training, providing partial support for its trainability in this population. Although impulsivity, and craving improved, only reductions in craving were linked to neurofeedback response, and patients were better able to increase the sensorimotor rhythm activity than decrease the theta activity.Ford, (2003)United KingdomFocus: AssessmentTo evaluate the psychometric properties of the Dartmouth Assessment of Lifestyle Inventory as a screening tool for substance use disorders, and the Leeds Dependence Questionnaire as a measure of dependence severity among detained psychiatric inpatients with severe mental disorders.Quantitative-Cross-sectional observationalLeeds Dependency Questionnaire (LDQ)Dartmouth Assessment of Lifestyle Inventory (DALI) A clinical assessment of substance use disorder using ICD−10 criteriaInstitution: Kneesworth House HospitalSecurity Level: MediumType: PatientAge Group: AdultsSex/Gender: MixedEthnicity: Not specifiedDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: 50–74Format: N/ADuration: N/AComponents: N/AThe DALI showed acceptable diagnostic accuracy for identifying both alcohol (74%) and drug disorders (83%). The LDQ demonstrated good concurrent validity and reliability with the DALI.Foster and Onyeukwu, (2003)United KingdomFocus: Staff Perceptions/AttitudesTo examine forensic nurses’ attitudes toward service users with substance misuse.Quantitative-Cross-sectional observationalSubstance Abuse Attitude Survey (SAAS) - Subscores: treatment intervention, treatment optimism, permissiveness, non-moralism and non-stereotypesInstitution: Not specifiedSecurity Level:MediumType: StaffAge Group: AdultsSex/Gender: MixedEthnicity: VariousDiagnosis: N/ASample Size: 50–74Format: N/ADuration: N/AComponents: N/AForensic nurses’ attitudes toward service users with substance misuse problems were suboptimal. Permissiveness scores were comparatively stronger, but treatment intervention and optimism scores were low. Some attitudinal differences were also observed by sex, nursing grade, and ethnicity.Glassmire et al., (2007)United StatesFocus: Treatment; Management; ImplementationTo describe the development, implementation, and evaluation of a substance misuse and mental illness treatment program in a forensic hospital, alongside outlining a skills-based counselling approach that integrates cognitive rehabilitation strategies.Quantitative-Uncontrolled pre–post (one-group)56 multiple-choice questions that were grouped onto two 28-item test forms so that 1 question from each topic was included on each formInstitution: Not specifiedSecurity Level:HighType: PatientAge Group: Not specifiedSex/Gender: Not specifiedEthnicity: Not specifiedDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: 50–74Format: GroupDuration: 12-week treatment cycleComponents:- Basic and skills training- 12-step treatment approach- Relapse prevention skills- The program: 1] Takes into account each patient’s current stage of readiness; 2] Employs motivational interviewing; 3] Utilizes cognitive remediation strategies during didactic groupsThe study’s outcome measure showed adequate internal consistency, and test form order did not influence total scores. Participants who completed pre- and post-testing demonstrated significant improvement over the 12-week program, providing support for the intervention’s feasibility and potential benefit in this population.Green et al., (2023)SwedenFocus: Assessment; Treatment; Implementation; Staff Perceptions/AttitudesTo explore staff experiences of implementing clinical guidelines for the assessment and treatment of co-occurring substance use and mental disorders in a high-security forensic psychiatric setting, including perceived barriers and facilitators to implementation and experiences of the process over the first year.Qualitative-InterviewAddiction Severity Index (ASI)Extended Alcohol Use Disorders Identification Test (AUDIT-E)Alcohol Effects Questionnaire (AEFQ)Structural Analysis of Social Behaviour (SASB)NORC Diagnostic Screen for Gambling Disorders (NODS)InterviewsInstitution: Not specifiedSecurity Level: HighType: StaffAge Group: AdultsSex/Gender: MixedEthnicity: Not specifiedDiagnosis: N/ASample Size:< 25Format: N/ADuration: N/AComponents: N/AStaff generally welcomed the introduction of substance use-specific clinical guidelines, but they reported needing more practical support to carry out assessments and deliver treatment. The implementation process was also shaped by tension between caregiving and security roles, mixed staff attitudes toward substance use, and a persistent mismatch between assessment and treatment capacity.Johnson et al., (2019)United KingdomFocus: Treatment; Management; ImplementationTo explore participants’ experiences of an Acceptance and Commitment Therapy substance misuse program, including its perceived strengths and limitations, its suitability for long-stay mental health service users with co-occurring mental health and substance misuse, as well as implementation feasibility.Qualitative-InterviewSemi-structured interviewsInstitution: Not specifiedSecurity Level: MultipleType: PatientAge Group: AdultsSex/Gender: MixedEthnicity: Majority White/EuropeanDiagnosis: Mixed psychiatric Sample Size: < 25Format: Group and IndividualDuration: 8 weeks long, consisting of a two-hour group session and one-hour individual/small group session, on a weekly basisComponents:- Acceptance and Commitment Therapy- Focus areas: motivation and values; the function of emotions/emotional avoidance; relationships; leisure; personal growth and health; work and education- Psychoeducational components pertaining to substance use and offending behaviour and its link between substance misuse and mental health- Skills and strategies to be able to resist / replace substance use, while acting in line with personal values (mindfulness skills, exploring difficult thoughts/cognitive fusion, willingness, urge surfing and self-compassion, relapse prevention, goal setting)Participants described the program as promoting greater awareness of personal values and the effects of substance use, while also supporting committed action, coping skill development, and broader personal growth. The use of metaphors and analogies were viewed positively, suggesting that the program’s approach was acceptable for service users.Kaur, Daffern and Thomas, (2009)AustraliaFocus: Treatment; Management; Staff Perceptions/AttitudesTo examine how often psychiatric nurses used the label “drug-seeking” when patients requested pro re nata (PRN) medication, and to assess whether patients with a history of illicit substance use, particularly those described as “drug-seeking,” received less helpful responses.Quantitative-Retrospective observationalChart review: Case files, medication chartsInstitution: The Thomas Embling Hospital (Victorian Institute of Forensic Mental Health)Security Level: Not specifiedType: StaffAge Group: AdultsSex/Gender: AdultsEthnicity: Not specifiedDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: 25–49Format: N/ADuration: N/AComponents: N/APatients with histories of amphetamine or opiate use were more likely to be described as “drug-seeking,” but this label was not used consistently and did not appear to meaningfully reduce the likelihood of PRN medication being administered. Substance use histories involving other drugs were not associated with the label, and patients with amphetamine or opiate use histories did not make more PRN requests.Kendrick, Basson and Taylor, (2002)United KingdomFocus: Screening; PrevalenceTo assess the reliability and validity of urine drug screening for illicit substances and to estimate the period prevalence of substance misuse within a high-secure hospital.Quantitative-Cross-sectional observational with embedded randomized componentClinical recordStandard clinical collection formUrine samplesInstitution: Broadmoor HospitalSecurity Level: HighType: PatientAge Group: AdultsSex/Gender: MixedEthnicity: Not specifiedDiagnosis: Not specifiedSample Size: 150–199Format: N/ADuration: N/AComponents: N/AUrine drug screening showed good reliability and validity for identifying illicit substance use. Testing practices improved over time, screening was not fully random, and the period prevalence of confirmed illicit substance use was low. There were some concerns resulting from test refusals.Krishnan and Ireland, (2025)United KingdomFocus: Treatment; Management; Implementation; Staff Perceptions/AttitudesTo explore psychosocial factors involved in the initiation and maintenance of substance use among forensic patients with dual diagnosis, and to examine the acceptability and feasibility of a novel group-based substance use intervention from the perspectives of both service users and service providers.Qualitative-InterviewSemi-structured interviewsInstitution: Not specifiedSecurity Level: HighType: Staff and patientAge Group: Not specifiedSex/Gender: Male patients; Not specified for staffEthnicity: Not specifiedDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: < 25Format: GroupDuration: 40 group sessions, in two-hour blocks, twice a weekComponents:- Cognitive Behavioural Therapy- Motivational InterviewingThe study identified multiple psychosocial risk factors underlying substance use in forensic patients with dual diagnosis and proposed two pathways of substance use behaviours. The intervention was generally viewed as acceptable by service users and providers. Participants highlighted the importance of group cohesion, facilitator skill, structural refinements to program content, and stronger throughcare as an enabling factor to treatment improvement.Lincourt et al., (2020)United StatesFocus: Screening; AssessmentTo examine the relationship between substance use information disclosed during clinical interviews and on the Minnesota Multiphasic Personality Inventory−2-Restructured Form Substance Abuse Scale (MMPI−2-RF SUB) items/scale among forensic psychiatric inpatients.Quantitative-Cross-sectional observationalMinnesota Multiphasic Personality Inventory−2-Restructured Form Substance Abuse Scale (MMPI−2-RF SUB)Chart reviewsInstitution: Not specifiedSecurity Level: HighType: PatientAge Group: AdultsSex/Gender: MixedEthnicity: VariousDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: 150–199Format: N/ADuration: N/AComponents: N/ASubstance use reporting differed across assessment methods, with some patients disclosing use in the clinical interview but not on the MMPI−2-RF SUB scale, and others showing the opposite pattern. MMPI−2-RF SUB scores were associated with substance-related variables from record review and showed incremental validity beyond other externalizing scales for identifying substance use problems.Long et al., (2010)United KingdomFocus: Treatment; Management; ImplementationTo examine the feasibility and acceptability of a gender-specific cognitive behavioural group intervention for women in a medium secure setting with histories of substance misuse, and to assess its impact on substance-related outcomes.Quantitative-Uncontrolled pre–post (one-group)Comprehensive Drinkers Profile (CPD)Severity of Dependence Scale (SDS)Short Inventory of Problems Lifetime Consequences (SIPL)The Coping Strategy Scale (CSS)Drug and Alcohol Taking Confidence Questionnaire (DTCQ)Alcohol and Drug Taking Consequences Questionnaire (ADCQ)Camberwell Assessment of Need, Forensic version (CANFOR)Brief Psychiatric Rating Scale Expanded (BPRS-E)Generalised Self-Efficacy Scale (GSES)Institution: St Andrews HealthcareSecurity Level: MediumType: PatientAge Group: PatientSex/Gender: FemaleEthnicity: Majority White/EuropeanDiagnosis: Not specifiedSample Size: 25–49Format: Group and IndividualDuration: 16 weeks - 11 75-min sessions, and an individual session at the end of the group program (30-min individual sessions run concurrently)Components: Cognitive Behavioural Therapy (for dual diagnosis, relapse prevention and gender-specific issues relating to trauma, mental health, index offence and lifestyle)The intervention was feasible for many participants, with about two-thirds completing treatment in preparation for lower-security settings and greater potential exposure to substances. Among completers, outcomes suggested improved substance-related self-efficacy, more favourable views of change, reduced substance-related symptoms, and increased self-efficacy.MacIntyre et al., (2004)United KingdomFocus: Screening; PrevalenceTo describe the extent of illicit substance use within a high-secure hospital over a three-year period using urine drug testing results.Quantitative-Retrospective observationalUrine drug screeningInstitution: The State Hospital, CarstairsSecurity Level: HighType: PatientAge Group: AdultsSex/Gender: MixedEthnicity: Not specifiedDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: ≥ 200Format: N/ADuration: N/AComponents: N/ARoutine urine testing suggested that in-hospital illicit substance use was rare. Although 10% of samples tested positive, most were attributable to prescribed medication, with only a small proportion representing true positives. These confirmed cases were concentrated in admission and continuing care areas rather than rehabilitation wards.Marcer, Mills and Clarke, (2016)United KingdomFocus: Treatment; ManagementTo evaluate the effectiveness of cognitive remediation therapy (CRT) for forensic inpatients with histories of substance misuse and/or head injury in a low secure unit.Quantitative-Uncontrolled pre–post (one-group)Hayling testBrixton testDigit Span (subtest of the Wechsler Adult Intelligence Scale)Zoo Map (subtest of the Behavioural Assessment of the Dysexecutive Syndrome)Institution: Southfield Low Secure Unit (Southern Health NHS Foundation Trust)Security Level: LowType: PatientAge Group: AdultsSex/Gender: MixedEthnicity: Not specifiedDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: < 25Format: IndividualDuration: 8 sessionsComponents: Cognitive remediation therapy (CRT)Participants showed improvement across most cognitive outcome measures. The analyses suggested that CRT produced reliable and clinically meaningful change for forensic inpatients in general, and those with histories of substance misuse and/or head injury.McFadden et al., 2020AustraliaFocus: Treatment; Management; ImplementationTo assess the feasibility, acceptability, and preliminary efficacy of a Substance Use Treatment Program for mentally ill offenders in an Australian secure forensic setting.Mixed methods-Quasi-experimental one-group pre–post (uncontrolled)Alcohol Use Disorders Identification Test (AUDIT)Drug Use Disorders Identification Test (DUDIT)Feasibility: Participant attendance; Treatment Entry Questionnaire (TEQ)Acceptability: Client Satisfaction Questionnaire (CSQ−8)Therapeutic alliance: Working Alliance Inventory-Short Form (WAI-SR)Drug Taking Confidence Questionnaire (DTCQ−8)Drug Related Locus of Control (DR-LOC)Levenson Multi-Dimensional Locus of Control Questionnaire (MD-LOC)Beliefs about Substance Use (BSU) questionnaireParticipant file review: Demographics, clinical, service utilizationQualitative interviewsInstitution: Not specifiedSecurity Level: HighType: PatientAge Group: AdultsSex/Gender: MixedEthnicity: VariousDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: 25–49Format: GroupDuration: 12 weeks (weekly sessions; two stages containing six sessions)Components:- Cognitive Behavioural Therapy- Motivational InterviewingThe program was feasible and acceptable in this high-secure forensic setting, with strong participation and high satisfaction. Results suggested improvement in locus of control and substance-related beliefs, although the program did not significantly improve confidence to resist substance use in high-risk situations.McKeown and Liebling, (1995)United KingdomFocus: Management; Staff Focus: Perceptions/AttitudesTo examine staff perceptions of illicit drug use among patients in a United Kingdom forensic hospital, including the nature and extent of the issue, current management approaches and their perceived effectiveness, priorities for improving management, and staff training needs.Quantitative-Cross-sectional observationalDrug misuse survey / questionnaire: Perceptions of the nature of the issues, how the issues are handled, perceived staff training needs, therapeutic needs of patients who misuse drugs, ideas for management of the issuesInstitution: Ashworth HospitalSecurity Level: HighType: StaffAge Group: Not specifiedSex/Gender: MixedEthnicity: Not specifiedDiagnosis: N/ASample Size: 100–149Format: N/ADuration: N/AComponents: N/AStaff perceptions of illicit drug use focused largely on cannabis and on problems related to the supply of substances and associated antisocial behaviour. The survey also highlighted a significant level of ignorance regarding illicit drugs and their usage. The data suggested limited staff knowledge about illicit drugs, insufficient support and guidance for managing the issue, and a need for more coordinated policy and workforce training.Miles et al., (2007)United KingdomFocus: Treatment; ManagementTo report findings from a one-year pilot evaluation of the Denis Hill Unit Substance Use Treatment Program, a three-stage integrated treatment model in a medium secure setting.Quantitative-Quasi-experimental with non-equivalent comparison groupUrine drug screenThree one-item 10-point rating scales, based on Graham et al. (2005), assessing participants’ beliefs about their substance useBeliefs about Substances questionnaireMarijuana Craving QuestionnaireA specifically designed satisfaction questionnaire at the end of each stage of treatment: To rate various aspects of the treatment program, including content and delivery, views regarding what they had learnt, and views on how the treatment could be improvedSociodemographic data collected from clinical filesInstitution: The Denis Hill UnitSecurity Level: MediumType: PatientAge Group: AdultsSex/Gender: MaleEthnicity: VariousDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: 25–49Format: GroupDuration: 12 weekly sessionsComponents:- Abstinence focus- Motivational interviewing- Psychoeducation- Relapse prevention approaches- Prochaska and DiClemente’s (1986) stages of change model of addictive behavioursMost patients had a prior history of substance use problems, and a substantial proportion of those who participated in the program were abstinent by the end of treatment and at follow-up. Program attendance was associated with remaining abstinent. Participants also reported improved insight, greater confidence in making substance-related changes, possible improvements in adaptive beliefs about substances and cannabis craving, and high satisfaction with the program.Miles, (2015)United KingdomFocus: Treatment; Management; ImplementationTo evaluate whether the integrated Substance Use Treatment Program changed participants’ substance-related beliefs and behaviours, whether potential gains were maintained at one- and three-year follow-up, and whether the program was acceptable regarding participant satisfaction and retention.Quantitative-Quasi-experimental non-randomized controlled trialMaudsley Addiction ProfileAlcohol Use Disorders Identification Test: Short VersionSeverity of Dependence ScaleBeliefs about Substances – WrightCannabis Craving QuestionnaireSpecifically devised participant satisfaction questionnaireInstitution: The Trevor Gibbens UnitSecurity Level: MediumType: PatientAge Group: AdultsSex/Gender: MixedEthnicity: VariousDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: 25–49Format: 25–49Duration: 12 two-hour sessionsComponents:- Abstinence focus- Motivational interviewing- Psychoeducation- Relapse prevention approachesProblematic substance use histories were common in this sample, and the program showed strong retention (high completion, low drop-out). Findings suggested support for abstinence over one year, improvements in adaptive substance-related beliefs and craving among attendees, high participant satisfaction, and potential longer-term benefit for abstinence at the three-year follow-up.Milosevic et al., (2018)CanadaFocus: Screening; Treatment; ManagementTo evaluate a manualized group-based substance use treatment program for forensic psychiatric inpatients in a medium secure hospital setting.Quantitative-Quasi-experimental non-randomized controlled trialLevel of Knowledge Questionnaire (LKQ)Drug Abuse Screening Test (DAST)Michigan Alcoholism Screening Test (MAST)Relapse Prevention Skills and Beliefs Questionnaire (RPQ)UrinalysisInstitution: Not specifiedSecurity Level: MediumType: PatientAge Group: AdultsSex/Gender: MixedEthnicity: Not specifiedDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: 75–99Format: Group and IndividualDuration: 38 sessions over a 5-month period (twice weekly basis for 1 h per session)Components:- Psychoeducation- Skills training- Cognitive Behavioural TherapyParticipants who completed the program showed improved substance-related knowledge and self-reported relapse prevention skills. Treatment completers and non-completers did not differ in time to first substance use or positive urine screens at 12- and 24-month follow-up.Morris and Moore, (2009)United KingdomFocus: Treatment; ManagementTo explore the potential effectiveness of a cognitive behavioural group intervention for offender patients with histories of substance misuse.Mixed methods-Pre-post (quant + qual)Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES)Psychological Inventory of Drug-Based Thinking Styles (PIDTS)A non-self-report measure of substance misuseSemi-structured interviewsInstitution: Broadmoor HospitalSecurity Level: HighType: PatientAge Group: AdultsSex/Gender: MaleEthnicity: Majority White/EuropeanDiagnosis: Mixed psychiatricSample Size: 25–49Format: GroupDuration: 9–14 months longComponents: Cognitive Behavioural TherapyThe group intervention was associated with improved awareness of substance misuse and its consequences, including less ambivalence, fewer substance-related thinking patterns justifying use, and greater recognition of abstinence-related challenges. Qualitative interview data suggested that some participants found the program helpful for strengthening abstinence goals and relapse prevention, although perceived benefit was not uniform across patients.Nicholls et al., (2011)CanadaFocus: Assessment; Treatment; Management; PrevalenceTo examine the implementation of the Short-Term Assessment of Risk and Treatability (START) within a large Canadian forensic psychiatric service, assess its psychometric properties when completed by multidisciplinary treatment teams, describe the clinical and risk profile of the patient cohort, and explore whether these profiles differed by sex, setting, or security level.Quantitative-Cross-sectional observationalThe Short-Term Assessment of Risk and Treatability (START)Institution: BC Forensic Psychiatric Services Commission System (Forensic Psychiatric Services)Security Level: MultipleType: PatientAge Group: AdultsSex/Gender: MixedEthnicity: Not specifiedDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: ≥ 200Format: N/ADuration: N/AComponents: N/ASTART demonstrated good psychometric performance and identified few patients as high risk across most domains, with substance abuse being the notable exception. Histories of substance abuse were common among both men and women, and substance abuse had the highest proportion of patients rated as high risk relative to the other START risk estimates.O'Shea, Dickens, (2015)United KingdomFocus: Screening; AssessmentTo evaluate the predictive validity of the Short-Term Assessment of Risk and Treatability (START) for unauthorised leave and substance misuse.Quantitative-Cohort observationalThe Short Term Assessment of Risk and Treatability (START)Institution: St Andrew’s HealthcareSecurity Level: MultipleType: PatientAge Group: AdultsSex/Gender: MixedEthnicity: VariousDiagnosis: MixedSample Size: ≥ 200Format: N/ADuration: N/AComponents: N/AThe START showed some predictive utility for unauthorised leave, but its scales did not consistently predict substance abuse.Oddie and Davies, (2009)United KingdomFocus: Treatment; Management; ImplementationTo conduct a pilot feasibility evaluation of a poly-substance misuse program delivered in a medium secure hospital.Mixed methods-Quasi-experimental one-group pre–post (uncontrolled)Semi-structured interviewsReadiness to Change Questionnaire- Treatment Version (RCQ-TV)Situational Confidence Questionnaire (SCQ−8)Final reports containing facilitator observations of stage of changeInstitution: Not specifiedSecurity Level: MediumType: MediumAge Group: AdultsSex/Gender: Not specifiedEthnicity: Majority White/EuropeanDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: < 25Format: Not specifiedDuration: Twice-weeklyComponents:- Motivational interviewing- Cognitive behavioral interventions- Psychosocial interventions- Relapse preventionParticipants reported varied expectations and experiences of the program, but overall feedback suggested perceived benefits and general support for the intervention. Motivation to change did not significantly improve at the group level, although confidence to resist substances increased in several situations, and self-reported stage of change was broadly consistent with facilitator ratings for most participants.Parsons et al., (2022)AustraliaFocus: Treatment; ManagementTo evaluate a group-based intervention for alcohol and drug use among incarcerated youth with mental illness hospitalised in a forensic psychiatric setting.Quantitative-Uncontrolled pre–post (one-group)Treatment Entry Questionnaire (TEQ)Brief Psychiatric Rating Scale (BPRS)Drug-Related Locus of Control (DRLOC)Drug-Taking Confidence Questionnaire (DTCQ) short versionInstitution: Not specifiedSecurity Level: Not specifiedType: PatientAge Group: YouthSex/Gender: MixedEthnicity: VariousDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: < 25Format: GroupDuration: Not specifiedComponents:- Motivational interviewing- Cognitive behavioural techniques- PsychoeducationFollowing the intervention, participants showed significant improvement in psychiatric symptoms and a shift toward greater internal locus of control.Penney, McLaren and Wilkie, (2021)CanadaFocus: Screening; PrevalenceTo describe urine drug screening practices and the prevalence of substance use within a large Canadian forensic psychiatric service.QuantitativeRetrospective observationalUrine drug screening (UDS)Institution: Not specifiedSecurity Level: MultipleType: PatientAge Group: AdultsSex/Gender: MixedEthnicity: VariousDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: 100–149Format: N/ADuration: N/AComponents: N/AOver the three-month study period, 10% of urine samples returned positive for a prohibited substance (most commonly cannabis or alcohol) while a similar proportion were diluted. Inpatients were tested more frequently than outpatients but were less likely to have positive results, and positive cases tended to undergo more frequent testing.Price, Wibberley, (2012)United KingdomFocus: Management; Staff Perceptions/AttitudesTo explore nurses’ perspectives on how procedures used to manage patients’ substance misuse, including searches and urine drug screening, affected nurse-patient relationships.Qualitative-InterviewInterviews: Guided by a schedule consisting of 10 open-ended questionsInstitution: Not specifiedSecurity Level: MediumType: StaffAge Group: AdultsSex/Gender: MixedEthnicity: Not specifiedDiagnosis: N/ASample Size: < 25Format: N/ADuration: N/AComponents: N/ANurses perceived that procedures used to manage substance misuse could undermine nurse-patient relationships given their intrusive nature. The extent of this impact depended partly on the type of procedure and on nurses’ communication skills. Partial strip searches were viewed as especially likely to damage relationships regardless of how they were conducted.Querengässer et al., 2019GermanyFocus: Treatment; Management; Staff Perceptions/AttitudesTo explore how patients and therapists interpret the therapeutic dynamics that precede premature treatment termination in forensic addiction treatment.Mixed methods-Retrospective cross-sectional + interviewsAuthor-developed questionnaire: Perceived causes and occasions for premature therapy termination; attitudes towards and assessed conformity to therapy requirementsSemi-structured interview: Assessment of possible causes and occasions for premature therapy termination; subjective narratives, (self-) criticism, therapy goal attainment, learning experiencesInstitution: Not specifiedSecurity Level: Not specifiedType: PatientAge Group: AdultsSex/Gender: Not specifiedEthnicity: Not specifiedDiagnosis: Primarily substance use disorderSample Size: 50–74Format: N/ADuration: N/AComponents: N/APatients and therapists often differed substantially in how they explained therapy failure. Patients emphasized factors such as psychological distress, conflict with other patients, and an unfavourable therapeutic environment. Therapists more often attributed failure to patients’ limited effort or unwillingness to change.Reiners et al., (2022)GermanyFocus: Treatment; ManagementTo describe the availability and clinical use of opioid agonist treatment (OAT) in German forensic clinics for dependency diseases, and to examine critical incidents and discharge outcomes.Quantitative-Cross-sectional observationalAuthor-created OAT questionnaire (13 items)Institution: Not specifiedSecurity Level: Not specifiedType: PatientAge Group: Not specifiedSex/Gender: Not specifiedEthnicity: Not specifiedDiagnosis: Primarily substance use disorderSample Size: 25–49Format: N/ADuration: N/AComponents: N/AOAT was available in only some forensic clinics for dependency diseases in Germany. Clinics offering this treatment did not differ from other clinics in rates of critical incidents or successful discharge, but they had higher rates of unsuccessful treatment termination. Among patients receiving OAT, discontinuation was often linked to ongoing substance use and/or refusal of urine screening.Ritchie et al., (2011)United KingdomFocus: Treatment; ManagementTo examine the effectiveness of a relapse prevention program for forensic patients with severe mental illness and substance misuse histories, including the profile of the substances used and high-risk situations identified by participants, changes in confidence and self-efficacy for coping with relapse risk, and the suitability of the evaluation measures employed.Qualitative-Interview~Semi-structured interviews (interpretative phenomenological analysis)Institution: The State Hospital, CarstairsSecurity Level: HighType: PatientAge Group: AdultsSex/Gender: MaleEthnicity: Not specifiedDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: < 25Format: Group and IndividualDuration: 28 three-hour sessionsComponents:- Cognitive behavioural therapy- Motivational interviewing - Prochaska and DiClemente’s (1986) stages of change model of addictive behaviours- Developmental risk factor model- Skills trainingParticipants described the program as helping them move from limited insight toward substance use to greater self-awareness, stronger coping skills, and a more hopeful future-oriented identity. The findings also highlighted the importance of group processes, interpersonal relationships, and a supportive therapeutic alliance in facilitating these changes.Ritchie et al., (2004)United KingdomFocus: Screening; Treatment; ManagementTo examine admissions data on substance misuse among patients admitted to the State Hospital, Carstairs, and to describe the outcomes of an alcohol and drug education and awareness intervention program.Quantitative-Uncontrolled pre–post (one-group)The Inventory of Drug Taking Situations (IDTS)Drug Taking Confidence Questionnaire (DTCQ)Multidimensional Locus of Control (MLOC)Stages of Change Questionnaire (SOC)Rosenberg Self-Esteem Scale (RSE)Institution: The State Hospital, CarstairsSecurity Level: HighType: PatientAge Group: Not specifiedSex/Gender: MaleEthnicity: Not specifiedDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: 75–99Format: Group and IndividualDuration: 28 three-hour sessions over a 14-week periodComponents:- Psychoeducation- Skills training- Cognitive behavioural therapyAlcohol, cannabis, and heroin were the substances most commonly identified by participants, with some geographic variation in such reporting. Following the relapse prevention program, participants showed higher confidence in their ability to resist future substance use.Ritchie et al., (2010)United KingdomFocus: Treatment; ManagementTo explore the perspectives of dual diagnosis patients on a relapse prevention program delivered in a special hospital.Quantitative-Multi-design (cross-sectional + pre–post)Study #1:-Semi-structured interview (full alcohol and drug use history)-Questionnaires: Drug Abuse Screening Test (DAST−20); Alcohol Dependence Scale (ADS); Case note dataStudy #2:-Alcohol knowledge questionnaire-Stages of Change Questionnaire-Multidimensional Locus of ControlInstitution: The State Hospital, CarstairsSecurity Level: HighType: PatientAge Group: AdultsSex/Gender: MaleEthnicity: Not specifiedDiagnosis: Primarily psychotic disorders (± comorbidities)Sample Size: 75–99Format: GroupDuration: 8 sessions in length (once per week, 1.5 h in length)Components: Prochaska and DiClemente’s (1986) stages of change model of addictive behavioursSubstance misuse was common in the sample, with alcohol and cannabis common and polysubstance use frequently reported. Evaluation of the relapse prevention program showed significant gains in alcohol and drug knowledge, but no meaningful changes in stage of change or locus of control.Sandbrook, Clark, and Cocksedge, (2015)United Kingdom & IrelandFocus: Assessment; Treatment; Management; Staff Perceptions/AttitudesTo examine the current extent and range of substance misuse interventions provided in medium secure units in the United Kingdom and Ireland.Quantitative-Cross-sectional observationalAuthor-designed survey: Levels of substance misuse; levels of specialized training for clinical staff; the provision and design of substance misuse services; the range of interventions to address substance misuseInstitution: Not specifiedSecurity Level: MediumType: Staff and patientAge Group: Adults (patients), Not specified (staff)Sex/Gender: MixedEthnicity: Not specifiedDiagnosis: Not specifiedSample Size: 50–74Format: N/ADuration: N/AComponents: N/AReported substance misuse rates in medium secure units have declined, while the availability of treatment has increased. Most units offered a range of internally resourced interventions, but many staff were not receiving sufficient training. Some services lacked a coordinated strategy consistent with best practice.Schaefer, Daffern and Ferguson, (2011)AustraliaFocus: Management; Prevalence; Staff Perceptions/AttitudesTo examine the prevalence of substance misuse and dependence among patients admitted to a secure forensic psychiatric hospital, to evaluate the validity of the substance use paralleling behaviour framework, and to assess whether patients with substance dependence histories, particularly opiates or amphetamines, were more likely to be labelled by staff as ‘drug-seeking.’Quantitative-Cross-sectional observationalThe Brief Psychiatric Rating Scale (BPRS)The Structured Clinical Interview for DSM-IV (SCID-I), Version 2.0, Section E–Substance Use Disorders moduleSubstance use paralleling behaviour (SUPB) questionnaire and checklist (developed by the authors)Institution: Thomas Embling HospitalSecurity Level: Not specifiedType: Staff and patientAge Group: Adults (patients), Not reported (staff)Sex/Gender: MixedEthnicity: Not specifiedDiagnosis: Not specifiedSample Size: 25–49Format: N/ADuration: N/AComponents: N/APatients with substance dependence history showed more substance use paralleling behaviours during hospitalization than those without such histories, and this pattern was especially pronounced among patients with amphetamine or opiate use. Patients with substance dependence also made more requests for pro re nata medication, while psychiatric symptom severity was not related to these behaviours. Findings supported the validity of the substance use paralleling behaviour framework.Svensson et al., (2024)SwedenFocus: Treatment; ManagementTo explore Swedish forensic psychiatric patients’ experiences and past, present, and future perspectives on substance use and substance use disorder care, including their experiences before admission, during forensic care, and regarding motivators and barriers affecting care and life after discharge.Qualitative-InterviewSemi-structured interviewsInstitution: Not specifiedSecurity Level:MediumType: PatientAge Group: AdultsSex/Gender: MaleEthnicity: Not specifiedDiagnosis: Primarily substance use disorderSample Size: < 25Format: N/ADuration: N/AComponents: N/AParticipants described substance use disorder care as complex and shaped by long-standing social and psychiatric difficulties. Although they often felt uneasy within forensic care, some expressed gratitude for such confined care. Participant accounts highlighted tensions between restriction and support and a desire for a more ordinary life after discharge.Tibber, Piek and Boulter, (2015)United KingdomFocus: Assessment; Treatment; ManagementTo conduct an evaluation of a secure forensic dual diagnosis service by assessing the viability of self-report measures for monitoring treatment outcomes, examining service effectiveness, and using these findings to inform program delivery and evaluation.Quantitative-Quasi-experimental one-group pre–post (uncontrolled)The Alcohol and Other Drugs Knowledge Questionnaire (KNOW)The Stages of Change and Treatment Eagerness Scale Version 5 (SOCRATES)The Treatment Motivation Questionnaire (TMQ)The Effectiveness of Coping Behaviours Inventory (ECBI)Institution: Not specifiedSecurity Level: MultipleType: PatientAge Group: AdultsSex/Gender: MaleEthnicity:VariousDiagnosis:Primarily psychotic disorders (± comorbidities)Sample Size: 75–99Format: Group and IndividualDuration: 33 weeksComponents:- Cognitive behavioural therapy- Motivational interviewing - Psychoeducation- Skills training- Cognitive behavioural therapy- Stages of Change and Stress-Vulnerability (Ingram and Luxton, 2005) modelsThe psychoeducational stage improved participants’ knowledge of drug issues, but this did not lead to broader changes on other outcome measures. Completion of the other stage was associated with increased external motivation for treatment, although this did not translate into greater readiness for change. The findings suggest that self-report measures are a feasible way to monitor outcomes in this forensic dual diagnosis settings.Van Der Laan, Janssen, (1996)NetherlandsFocus: Screening; Treatment; ManagementTo describe a program developed to address substance misuse within a Dutch forensic hospital.Qualitative-Case studyUrine drug screeningPatient letter about drug dealing/usePatient self-report / qualitative feedbackInformal physical fitness testsInstitution: Dr Henri Van der Hoeven ClinicSecurity Level: Not specifiedType: PatientAge Group: AdultsSex/Gender: MixedEthnicity: Not specifiedDiagnosis: Not specifiedSample Size: < 25Format: GroupDuration: Not specifiedComponents: Not specifiedThe program appeared to strengthen recognition of substance abuse as a serious issue at the hospital and contributed to greater staff cohesion around responding to drug use. Patients who completed the group generally viewed it as helpful for understanding their substance use, resisting relapse, and developing hope through shared experiences and group belonging. Those who dropped out were more likely to engage in drug use upon leaving the program.Wettermann, Völlm and Schläfke, (2020)GermanyFocus: Treatment; ManagementTo compare the relative effectiveness of the Reasoning and Rehabilitation Program and Dialectical Behavioral Therapy-Forensic in improving mental flexibility, planning, and problem solving, among addicted offenders.Quantitative-Quasi-experimental one-group pre–post (uncontrolled)The Trail Making Test (TMT-B)Farbe-Wort-Interferenz-Test (FWIT)Turm von London [Tower of London] (TL-D)Regensburger Wortflüssigkeits Test [a word fluency test] (RWT)Mental speed [as the basis of all intellectual performances] was assessed using the Zahlen-Verbindungs-Test [a number-connection test] (ZVT)Sociodemographic, clinical, and criminogenic data, namely age, school graduation, professional qualification, IQ, length of stay, previous convictions, index offense, diagnosed substance dependence or harmful use, and diagnosed personality disorder~Note: The measured constructs were cognitive flexibility, ability to inhibit cognitive interference, cognitive performance/mental speed, divergent reasoning, and problem solving/convergent reasoningInstitution: Level: Not specifiedSecurity Level: Not specifiedType: PatientAge Group: AdultsSex/Gender: MaleEthnicity: Not specifiedDiagnosis: Primarily personality disorders (± comorbidities)Sample Size: 100–149Format: Group and IndividualDuration: Not specifiedComponents:- Cognitive behavioural therapy- Dialectical Behavioral Therapy- Skills training- Mindfulness- Psychoeducation- Anti-aggression training- Occupational therapy- Sport sessionsNo treatment group showed superior improvement across the measured outcomes. Participants in all groups improved on most cognitive measures, with the only notable between-group difference favouring Reasoning and Rehabilitation over DBT-F on divergent reasoning/word fluency.Whyte and Harrison, (2004)United KingdomFocus: Staff Perceptions/Attitudes; PrevalenceTo examine staff perceptions of the prevalence and impact of substance misuse in secure psychiatric units, and to assess the availability of related treatment services.Quantitative-Cross-sectional observationalQuestionnaire (2 sections): 1] To confirm the nature of the unit, including their own discipline and seniority; and then to rate their subjective impression of the substance misuse in their unit. 2] To describe the features of each of the substance misuse treatment services available to patients on their unit, no matter how informal the ‘service’ or where it was provided.Institution: Not specifiedSecurity Level: MultipleType: StaffAge Group: Not specifiedSex/Gender: Not specifiedEthnicity: Not specifiedDiagnosis: N/ASample Size: 25–49Format: N/ADuration: N/AComponents: N/AStaff viewed substance misuse as a major issue with substantial impact, but service provision was limited. Where services existed, they tended to focus on awareness raising and relapse prevention as opposed to treatment of current substance misuse. Few units referred patients to local National Health Service addiction services. Extracted Data from Included Studies Appendix E Substance Use Terminology -Drug abuse-Drug misuse-Drug use disorder-Illicit drug use-Illicit substance misuse-Problematic use-Substance abuse-Substance abuse disorders-Substance addiction-Substance addiction disorders-Substance dependence-Substance dependence disorder-Substance misuse-Substance use-Substance use disorder Appendix F Extracted Data from Program-Focused StudiesAuthor(Year)RegionClinical SettingProgram FormatProgram DurationProgram ComponentsBaker et al., (2014)United KingdomSt Andrew’s HealthcareGroup and IndividualNot specified- Cognitive behavioural therapy- Practicing substance refusal skills via psychoeducation, group discussion, group exercises and role play- Weekly individual homework exercisesDownsworth and Jones, (2014)United KingdomRoseberry Park HospitalGroup20 sessions- Cognitive behavioural group treatment- Target areas: motivation to change; personal awareness and responsibility raising; relapse prevention; lifestyle changeEdwards et al., (2011)United KingdomNot specifiedNot specifiedNot specified- Motivational approach- Contingency management component (for negative drug screens)- Structured goal setting- Drug refusal skills training- Psychoeducation- Relapse prevention trainingGlassmire et al., (2007)United StatesNot specifiedGroupNot specified- Basic and skills training- 12-step treatment approach- Relapse-prevention skills- The program: 1] Considers each patient’s current stage of readiness; 2] Employs motivational interviewing; 3] Utilizes cognitive remediation strategies during didactic groupsJohnson et al., (2019)United KingdomNot specifiedGroup and Individual8 weeks long, consisting of a two-hour group session and one-hour individual/small group session, on a weekly basis- Acceptance and Commitment Therapy- Focus areas: motivation and values; the function of emotions/emotional avoidance; relationships; leisure; personal growth and health; work and education- Psychoeducational components pertaining to substance use and offending behaviour and its link between substance misuse and mental health- Skills and strategies to be able to resist / replace substance use, while acting in line with personal values (mindfulness skills, exploring difficult thoughts/cognitive fusion, willingness, urge surfing and self-compassion, relapse prevention, goal setting)Krishnan and Ireland, (2025)United KingdomNot specifiedGroup40 group sessions, in two-hour blocks, twice a week- Cognitive Behavioural Therapy- Motivational InterviewingLong et al., (2010)United KingdomSt Andrews HealthcareGroup and Individual- 16 weeks - Eleven 75-min sessions, and an individual session at the end of the group program (30-min individual sessions run concurrently)- Cognitive Behavioural Therapy: For dual diagnosis, relapse prevention and gender-specific issues relating to trauma, mental health, index offence and lifestyleMarcer, Mills, and Clarke, (2016)United KingdomSouthfield Low Secure Unit (Southern Health NHS Foundation Trust)Individual8 sessions- Cognitive remediation therapyMcFadden et al., (2020)AustraliaNot specifiedGroup12 weeks (weekly sessions; two stages containing six sessions)- Cognitive behavioural therapy- Motivational interviewingMiles et al., (2007)United KingdomThe Denis Hill UnitGroup12 weekly sessions- Abstinence focus- Motivational interviewing- Psychoeducation- Relapse prevention approaches- Prochaska and DiClemente’s (1986) stages of change model of addictive behavioursMiles, (2015)United KingdomThe Trevor Gibbens UnitGroup12 two-hour sessions- Abstinence focus- Motivational interviewing- Psychoeducation- Relapse prevention approachesMilosevic et al., (2018)CanadaNot specifiedGroup and Individual38 sessions over a 5-month period (twice weekly basis for 1 h per session)- Psychoeducation- Skills training- Cognitive behavioural therapyMorris and Moore, (2009)United KingdomBroadmoor HospitalGroup9–14 months long- Cognitive behavioural therapyOddie and Davies, (2009)United KingdomNot specifiedNot specifiedTwice weekly- Motivational interviewing- Cognitive behavioral interventions- Psychosocial interventions- Relapse preventionParsons et al., (2022)AustraliaNot specifiedGroupNot specified- Motivational interviewing- Cognitive behavioural techniques- PsychoeducationRitchie et al., (2004)United KingdomThe State Hospital, CarstairsGroup and Individual28 three-hour sessions over a 14-week period- Psychoeducation- Skills training- Cognitive behavioural therapyRitchie et al., (2010)United KingdomThe State Hospital, CarstairsGroup8 sessions in length (once per week, 1.5 h in length)- Prochaska and DiClemente’s (1986) stages of change model of addictive behavioursRitchie et al., (2011)United KingdomThe State Hospital, CarstairsGroup and Individual28 three-hour sessions- Cognitive behavioural therapy- Motivational interviewing- Prochaska and DiClemente’s (1986) stages of change model of addictive behaviours- Developmental risk factor model- Skills trainingTibber et al., (2015)United KingdomNot specifiedGroup and Individual33 weeks- Cognitive behavioural therapy- Motivational interviewing- Psychoeducation- Skills training- Cognitive behavioural therapy- Stages of Change and Stress-Vulnerability models (Ingram and Luxton, 2005)Van Der Laan, Janssen, (1996)NetherlandsDr Henri Van der Hoeven ClinicGroupNot specified- Relapse prevention model developed by Marlatt and co-workers (Cummings et al., 1980, Marlatt and Gordon, 1985)- Group psychotherapy- Sports- Music lessonsWettermann et al., (2020)GermanyNot specifiedGroup and IndividualNot specified- Cognitive behavioural therapy- Dialectical behavioral therapy- Skills training- Mindfulness- Psychoeducation- Anti-aggression training- Occupational therapy- Sport sessions Extracted Data from Program-Focused Studies References